Acurx Pharmaceuticals Inc
ACXP0.292USD
-0.015-4.82%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
6.54MMarket Cap
LossP/E TTM
Acurx Pharmaceuticals Inc
0.292
-0.015-4.82%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
33.02%-2.05M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-180.68%-4.20M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
0.31%-1.50M
17.31%-2.18M
-503.58%-1.99M
-242.88%-1.88M
-56.31%-1.50M
-247.48%-2.64M
55.05%-329.81K
39.16%-547.14K
---959.75K
---758.76K
---733.75K
---899.29K
Net income from continuing operations
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Other non-cash items
----
----
----
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
-100.00%0.00
--0.00
--0.00
---66.50K
17.28%916.76K
--0.00
--0.00
--0.00
--781.70K
Change in working capital
-401.30%-345.98K
97.75%-6.98K
-12.22%165.19K
-98.96%11.05K
62.53%114.83K
-132.56%-310.15K
-64.99%188.19K
1323.61%1.06M
145.57%70.65K
159.70%952.46K
138.61%537.50K
-105.85%-86.80K
51.05%-155.03K
340.50%366.75K
-658.81%-1.39M
1101.32%1.48M
57.75%-316.71K
---152.50K
--249.14K
---148.15K
---749.66K
-Change in receivables
-60.42%51.13K
135.81%46.25K
---46.25K
---51.13K
--129.16K
---129.16K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-Change in prepaid expenses
25.18%-61.45K
42135.19%22.70K
388.88%45.59K
-83.28%19.50K
-240.75%-82.13K
-100.07%-54.00
92.86%-15.78K
-4.84%116.66K
4.48%58.35K
-69.04%72.85K
-18.77%-220.95K
1259.48%122.60K
118.31%55.85K
680.69%235.28K
-3624.69%-186.03K
1583.22%9.02K
-962.90%-304.96K
---40.52K
--5.28K
---608.00
--35.34K
-Change in payables and accrued expense
-595.04%-335.66K
58.04%-75.92K
-18.69%165.85K
-95.49%42.67K
451.39%67.80K
-120.57%-180.94K
-71.20%203.97K
694.05%945.43K
105.83%12.30K
569.04%879.61K
158.71%708.20K
-110.79%-159.15K
-1694.12%-210.88K
217.41%131.47K
-594.62%-1.21M
1099.33%1.47M
98.50%-11.75K
---111.98K
--243.87K
---147.54K
---785.00K
-Change in other current assets
----
----
----
----
----
----
----
----
----
----
--50.25K
---50.25K
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
33.02%-2.05M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-180.68%-4.20M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
0.31%-1.50M
17.31%-2.18M
-503.58%-1.99M
-242.88%-1.88M
-56.31%-1.50M
-247.48%-2.64M
55.05%-329.81K
39.16%-547.14K
---959.75K
---758.76K
---733.75K
---899.29K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
-33.73%2.99M
-95.79%194.55K
--1.59M
-90.96%320.21K
--4.51M
461963800.00%4.62M
-100.00%0.00
--3.54M
----
---1.00
--3.70M
-100.00%0.00
----
-100.00%0.00
-100.00%0.00
1216.28%14.80M
--0.00
--728.54K
--2.19M
--1.12M
--0.00
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--66.50K
--0.00
Net cash flow from common stock issuance/repurchase
-30.49%2.99M
-91.90%194.55K
--1.59M
-90.96%320.21K
--4.30M
--2.40M
-100.00%0.00
--3.54M
----
--0.00
--3.70M
-100.00%0.00
----
-100.00%0.00
-100.00%0.00
3152.26%14.80M
--0.00
--1.79M
--1.74M
--454.98K
--0.00
Proceeds from issuance of warrants
----
-100.00%0.00
--0.00
-100.00%0.00
--210.20K
--2.22M
-100.00%0.00
--73.00
----
--0.00
--13.00
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
----
----
----
----
---1.00
----
----
----
----
-100.00%0.00
-100.00%0.00
--0.00
---1.06M
--455.87K
--602.68K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-33.73%2.99M
-95.79%194.55K
--1.59M
-90.96%320.21K
--4.51M
461963800.00%4.62M
-100.00%0.00
--3.54M
----
---1.00
--3.70M
-100.00%0.00
----
-100.00%0.00
-100.00%0.00
1216.28%14.80M
--0.00
--728.54K
--2.19M
--1.12M
--0.00
Net cash flow
Beginning cash balance
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
308.10%12.96M
324.44%14.46M
765.85%17.10M
65.92%2.63M
27.87%3.18M
--3.41M
--1.97M
--1.58M
--2.48M
Current period cash flow changes
-35.22%937.17K
-587.33%-2.06M
71.42%-598.29K
-230.15%-2.56M
174.85%1.45M
128.21%421.86K
-238.17%-2.09M
198.81%1.97M
-3.03%-1.93M
0.31%-1.50M
157.47%1.52M
-113.76%-1.99M
-242.88%-1.88M
-548.83%-1.50M
-284.09%-2.64M
3605.66%14.47M
39.16%-547.14K
---231.22K
--1.43M
--390.41K
---899.29K
Ending cash balance
-47.94%4.64M
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
308.10%12.96M
324.44%14.46M
765.85%17.10M
65.92%2.63M
--3.18M
--3.41M
--1.97M
--1.58M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
